The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice
Open Access
- 30 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 936
Abstract
B-cell formation, development, and differentiation are complex processes regulated by several mechanisms. Recently, there has been growing evidence indicating that microRNAs (miRNAs) are important for normal B-cell lineage development. miRNAs are small non-coding RNA molecules, about 20–22 nucleotide in length, that play an important role in regulating gene expression. They pair with specific messenger RNAs (mRNAs), resulting in mRNAs translational repression or degradation. Here, we review current research about the function of miRNAs in the aspects of B-cell physiology and pathology. We start by introducing the process of miRNA biogenesis. We will then focus on the role of miRNAs during B-cell lineage commitment and development in the bone marrow, followed by a discussion of miRNAs’ role in subsequent peripheral B-cell activation, proliferation, and final differentiation (including B-cell central tolerance and autoimmunity). We list and describe several examples to illustrate miRNAs’ role in the development of B-cell lymphoma, both as oncogenes and tumor suppressor genes. Finally, we delineate the potential value of miRNAs in diagnosing B-cell lymphoma, predicting clinical outcomes, and modulating the efficiency of anticancer treatments. Despite the vast amount of research conducted on miRNAs in recent years, it is still necessary to increase and further strengthen studies on miRNAs and their targets to promote a better understanding on B-cell development and as a result, construct more effective treatments against B-cell disease.Keywords
Funding Information
- Natural Science Foundation of Hubei Province (2015CFA080)
- National Natural Science Foundation of China (31500709, 81722002)
This publication has 89 references indexed in Scilit:
- Differential microRNA Profile and Post-Transcriptional Regulation Exist in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesJournal of Clinical Immunology, 2014
- Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)International Journal of Hematology, 2013
- MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimenInternational Journal of Hematology, 2012
- Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell LymphomaThe American Journal of Pathology, 2012
- Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphomaAnnals of Hematology, 2011
- Onco‐miR‐155 targets SHIP1 to promote TNFα‐dependent growth of B cell lymphomasEMBO Molecular Medicine, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA ClustersCell, 2008
- MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-MybCell, 2007
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002